Relaciones con Inversores

 
Una inversión saludable en un futuro más saludable.
 
Cryo-Cell es una empresa que cotiza en bolsa desde 1991. Estamos regida por la Securities and Exchange Commission, y nuestras acciones comunes operan bajo el nombre OTC QB: símbolo CCEL. Nos especializamos en la conservación de células madre para uso familiar.

 

Cryo-Cell Reports Fiscal Third Quarter 2016 Results

OLDSMAR, Fla. – October 18, 2016 – Cryo-Cell International, Inc. (the “Company”) (OTC:QB Markets Group Symbol: CCEL), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2016.
 
Financial Results 
 
Revenue         
               
Consolidated revenues for the third quarter of fiscal 2016 were $6.3 million compared to $5.4 million for the third quarter of fiscal 2015.  The revenues for the third quarter of fiscal 2016 consisted of $5.6 million in processing and storage fees, $609,000 in licensee income, and $88,000 in product revenue, compared to $5.0 million in processing and storage fees, $169,000 in licensee income and $266,000 in product revenue for the third quarter of fiscal 2015.  

Read More


Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2016 Financial Results

OLDSMAR, Fla. – July 11, 2016 – Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2016. 
 
Financial Results
 
Revenue
Consolidated revenues for the second quarter of fiscal 2016 were $5.8 million compared to $5.0 million for the second quarter of fiscal 2015.  The revenues for the 2016 quarter consisted of $5.3 million in processing and storage fee revenue, $357,000 in licensee and royalty income and $66,000 in product revenue compared to $4.8 million in processing and storage fee revenue, $169,000 in licensee and royalty income and no product revenue for the 2015 quarter.

Read More


Cryo-Cell Reports Fiscal First Quarter 2016 Financial Results

OLDSMAR, Fla. – April 14, 2016 – Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 29, 2016.  
 
Financial Results
 
Revenue
 
Consolidated revenues for the first quarter of fiscal 2016 were $5.2 million compared to $4.8 million for the first quarter of fiscal 2015, a 6% increase.  The revenues for the first quarter of fiscal 2016 consisted of $5.0 million in processing and storage fee revenue and $132,000 in product revenue compared to $4.7 million in processing and storage fees and $169,000 in licensee income for the first quarter of fiscal 2015.

Read More